KK8123

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KK8123, covering 2025-11-14 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia [Phase 1, Phase 2]